Correlation Between Quest PharmaTech and BioCryst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Quest PharmaTech and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quest PharmaTech and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quest PharmaTech and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Quest PharmaTech and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quest PharmaTech with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quest PharmaTech and BioCryst Pharmaceuticals.
Diversification Opportunities for Quest PharmaTech and BioCryst Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Quest and BioCryst is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Quest PharmaTech and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Quest PharmaTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quest PharmaTech are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Quest PharmaTech i.e., Quest PharmaTech and BioCryst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Quest PharmaTech and BioCryst Pharmaceuticals
Assuming the 90 days horizon Quest PharmaTech is expected to under-perform the BioCryst Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Quest PharmaTech is 1.08 times less risky than BioCryst Pharmaceuticals. The pink sheet trades about -0.07 of its potential returns per unit of risk. The BioCryst Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,092 in BioCryst Pharmaceuticals on September 14, 2024 and sell it today you would lose (332.00) from holding BioCryst Pharmaceuticals or give up 30.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Quest PharmaTech vs. BioCryst Pharmaceuticals
Performance |
| Timeline |
| Quest PharmaTech |
| BioCryst Pharmaceuticals |
Quest PharmaTech and BioCryst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Quest PharmaTech and BioCryst Pharmaceuticals
The main advantage of trading using opposite Quest PharmaTech and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quest PharmaTech position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.| Quest PharmaTech vs. Coya Therapeutics, Common | Quest PharmaTech vs. Cue Biopharma | Quest PharmaTech vs. Lantern Pharma | Quest PharmaTech vs. Fennec Pharmaceuticals |
| BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |